|
11. |
Effects of Sympathectomy and Nitric Oxide Synthase Inhibition on Vascular Actions of Insulin in Humans |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 586-589
Claudio Sartori,
Lionel Trueb,
Pascal Nicod,
Urs Scherrer,
Preview
|
|
摘要:
Insulin exerts cardiovascular actions by stimulating nitric oxide (NO) release and sympathetic neural outflow. It is unclear, however, whether insulin stimulates muscle blood flow (and NO release) by a direct action at the vasculature and/or by stimulating neural vasodilator mechanisms. In these studies we used patients with regional sympathectomy to examine the vascular actions of insulin in the presence and absence of sympathetic vasoconstrictor and vasodilator innervation. A 2-hour insulin (6 pmol/kg per minute)/glucose clamp increased muscle blood flow in both innervated and denervated limbs by roughly 40% (P<0.01 versus baseline for both limbs). The vasodilation reached its maximum within the first 30 to 45 minutes of insulin/glucose infusion in sympathetically denervated limbs, but only at the end of the infusion in innervated limbs (P<0.01, denervated versus innervated limb). Infusion of a NO synthase inhibitor (NG-monomethyl-L-arginine [L-NMMA]) increased baseline arterial pressure, abolished the vasodilation in the denervated limb, and led to a significant additional increase in arterial pressure during the clamp, but did not alter whole body glucose uptake. Our data indicate that insulin stimulates blood flow in sympathectomized limbs by a direct action at the vasculature. This effect is mediated by stimulation of NO release and appears to be masked by the sympathetic vasoconstrictor tone in innervated limbs.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
12. |
Sex Steroids, Insulin, and Arterial Stiffness in Women and Men |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 590-597
Erik Giltay,
Jan Lambert,
Louis Gooren,
Jolanda Elbers,
Mieke Steyn,
Coen Stehouwer,
Preview
|
|
摘要:
Arterial stiffness may be influenced by sex steroids and insulin; the association with fasting insulin level may be stronger in women than in men. Therefore, we analyzed the effects of sex steroid administration on (1) arterial stiffness and (2) the relationship between fasting insulin level and arterial stiffness. Twelve male-to-female transsexuals were treated with ethinyl estradiol and cyproterone acetate, and 18 female-to-male transsexuals were treated with testosterone esters, with assessments made at baseline and after 4 and 12 months. Changes in distensibility and compliance coefficients (DC and CC, respectively) of the common carotid artery, femoral artery (FA), and brachial artery (BA) were analyzed in relation to changes in fasting plasma levels of glucose, insulin, HDL-cholesterol, and triglycerides. After 4 months of estrogens and antiandrogens in men, significant reductions in the CC and DC of the FA (P=0.006 andP=0.04, respectively) and BA (P=0.04 andP=0.04, respectively) were observed. In women, testosterone, on average, did not affect DC or CC, but the changes in fasting insulin level were strongly negatively associated with changes in the CC and DC, especially in the FA and BA. These associations were significantly less strong in genetic men and were independent of age, mean arterial pressure, and glucose and lipid levels. This experimental study shows (1) that short-term administration of estrogens and antiandrogens increases FA and BA stiffness in men and (2) that the fasting insulin level is a stronger determinant of arterial stiffness in women than in men.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
13. |
Heart Rate-Dependent Stiffening of Large Arteries in Intact and Sympathectomized Rats |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 598-602
Luca Mircoli,
Arduino Mangoni,
Cristina Giannattasio,
Giuseppe Mancia,
Alberto Ferrari,
Preview
|
|
摘要:
In the anesthetized rat, acute increases in heart rate are accompanied by a reduction in arterial distensibility, which is a significant phenomenon in elastic-type vessels such as the common carotid but much less evident in muscle-type vessels such as the femoral artery. Because the sympathetic nervous system importantly reduces arterial distensibility, the present study aimed to determine whether sympathetic influences (1) are involved in the heart rate-dependent changes in arterial distensibility and (2) exert differential effects on elastic-type versus muscle-type arteries. To address this issue, 9 sympathectomized (6-hydroxydopamine) and 10 vehicle-treated, 12-week-old, pentobarbitone-anesthetized Wistar-Kyoto rats were subjected to atrial pacing via a transjugular catheter at 5 different randomly sequenced rates (280, 310, 340, 370, and 400 bpm). After each step, spontaneous sinus rhythm was allowed to return to normal. Common carotid and femoral artery diameters were measured by an echo Doppler device (NIUS 01), and blood pressure was measured via catheter inserted into the contralateral vessel. Arterial distensibility was calculated over the systolic-diastolic pressure range according to the Langewouters formula. In the common carotid artery, progressive increases in heart rate determined progressive and marked reductions of distensibility (range, 15% to 43%) in sympathectomized and intact rats. In the femoral artery, the stiffening effect of tachycardia was present in sympathectomized rats (range, 21% to 42%), at variance with the inconsistent changes observed in intact rats. In conclusion, our experiments support the notions (1) that in predominantly elastic-type arteries, the stiffening effect of tachycardia is exerted independently of sympathetic modulation of the vessel wall properties and (2) that in predominantly muscle-type arteries, removal of sympathetic influences unmasks the stiffening effect of tachycardia.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
14. |
Angiotensin II-Stimulated Induction ofsis-Inducing Factor Is Mediated by Pertussis Toxin-Insensitive GqProteins in Cardiac Myocytes |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 603-608
Rachel Hunt,
G. Bhat,
Kenneth Baker,
Preview
|
|
摘要:
The Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway is stimulated by angiotensin II (Ang II) via the type 1 receptor after acute pressure overload in the heart. The purpose of this study was to determine whether activation of the JAK-STAT pathway by Ang II is dependent on G proteins. Ang II (100 nmol/L for 120 minutes) caused formation ofsis-inducing factor (SIF) complexes and tyrosine phosphorylation of STAT proteins in neonatal rat ventricular myocytes. The percentage of change in Ang II-stimulated SIF induction was not affected by pertussis toxin (PTX) or GP antagonist-2A, compounds that inhibit activation of Giand Goproteins. In contrast, GP antagonist-2A, a peptide that selectively inhibits activation of Gqproteins, completely abolished Ang II-stimulated SIF induction and STAT3 tyrosine phosphorylation. Pretreatment of cardiac myocytes with U73122, an inhibitor of phosphatidylinositol-specific phospholipase C (PLC) activity, decreased Ang II-stimulated SIF induction and STAT3 tyrosine phosphorylation in a dose-dependent manner. Chelation of intracellular Ca2+with BAPTA-AM did not alter Ang II-stimulated SIF induction. In contrast, pretreatment of cardiac myocytes with Ro-31-8220, a potent and specific inhibitor of protein kinase C (PKC), decreased Ang II-stimulated SIF induction in a dose-dependent manner. Ang II-stimulated SIF induction was abolished in cardiac myocytes after downregulation of PKC by treatment with PMA. From these data, we conclude that Ang II-stimulated SIF induction and STAT3 tyrosine phosphorylation is mediated by PTX-insensitive G proteins through a Gq-PLC-PKC-mediated pathway in neonatal rat ventricular myocytes.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
15. |
Apoptosis, Coronary Arterial Remodeling, and Myocardial Infarction After Nitric Oxide Inhibition in SHR |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 609-616
Yuko Ono,
Hidehiko Ono,
Hiroaki Matsuoka,
Takahiro Fujimori,
Edward Frohlich,
Preview
|
|
摘要:
This study was designed to investigate the relationship between apoptosis (programmed cell death) and coronary arterial remodeling in spontaneously hypertensive rats (SHR) following prolonged nitric oxide synthesis inhibition. In addition, we evaluated whether the development of coronary arterial smooth muscular cell apoptosis was related to hemodynamics or to vascular hypertrophy. Three groups of 20-week-old male SHR were investigated: controls, and two groups that received two doses of NG-nitro-L arginine (L-NAME, 50 mg/L and 80 mg/L) each for 3 weeks. Mean arterial pressure and total peripheral resistance index increased whereas cardiac index diminished with L-NAME. Pathohistological study demonstrated increased pericardiac fibrosis and coronary arterial injury score in the L-NAME group in a dose-dependent manner. The high dose of L-NAME (Group 3) produced myocardial infarction in 78% of the rats. The wall:lumen ratio of epicardial coronary arteries was greater in L-NAME treated SHR (0.23±0.02 versus 0.16±0.02;P<0.05) and was associated with markedly increased apoptosis (15.3±6 versus 1.9±1;P<0.05) without smooth muscle cell proliferation (PCNA positive cells). Apoptosis occurred predominantly in hypertrophic coronary arterial smooth muscular cells; myocardial infarction and ventricular fibrosis were exacerbated by impaired hemodynamics induced by L-NAME. These data suggest that coronary endothelial dysfunction and myocardial ischemic disease induced by L-NAME were responsible for apoptosis of coronary arterial smooth muscle cells, myocardial fibrosis, and infarction, all pathological findings that are consistent with what may be found in clinical hypertensive heart disease.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
16. |
In Vivo Study of AT1and AT2Angiotensin Receptors in Apoptosis in Rat Blood Vessels |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 617-624
Quy Diep,
Jin-Sheng Li,
Ernesto Schiffrin,
Preview
|
|
摘要:
In vitro experiments suggest that angiotensin II (Ang II) may cause growth via angiotensin type 1 (AT1) receptors and apoptosis via angiotensin type 2 (AT2) receptors. To answer the question of whether AT1or AT2receptor activation could induce apoptosis in the vasculature in vivo, Wistar rats were infused for 7 days with Ang II (120 ng · kg−1· min−1subcutaneously) and treated with the AT2receptor antagonist PD 123319 (30 mg · kg−1· d−1subcutaneously) or the AT1receptor antagonist losartan (10 mg · kg−1· d−1orally). Apoptosis in thoracic aorta was quantified by radiolabeled DNA laddering and by terminal deoxynucleotide transferase-mediated dUTP nick end-labeling. The expression of p53, bax, bcl-2, and caspase-3, which play critical roles in apoptotic signaling, was examined by Western blot analysis. The mRNA expression of AT1and AT2receptors was determined by reverse transcription-polymerase chain reaction. The increase in systolic blood pressure and aortic growth induced by Ang II infusion was completely prevented by losartan alone or losartan given with PD 123319, whereas PD 123319 resulted in a greater increase in systolic blood pressure and aortic growth than Ang II alone. Radiolabeled DNA laddering showed that Ang II infusion±losartan or PD 123319 significantly increased apoptosis (147±8%, 178±20%, and 238±41%, respectively,P<0.05 compared with control). Expression of bax and active forms of caspase-3 was increased in the Ang II+PD 123319 group, whereas the expression of p53 and bcl-2 was not significantly different in all groups. The expression of AT1and AT2receptor mRNA was downregulated by losartan and PD 123319, respectively. Thus, when AT1or AT2receptors are stimulated in vivo, apoptosis is enhanced in the media of blood vessels. In the case of AT1receptor stimulation, this may occur secondary to vascular growth and modulate the latter. Both bax and caspase-3 participate in the pathways of apoptosis triggered by in vivo AT1receptor stimulation.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
17. |
Genome Scan for Blood Pressure Loci in Mice |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 625-630
Fred Wright,
Daniel O'Connor,
Elizabeth Roberts,
Greg Kutey,
Charles Berry,
Lisa Yoneda,
David Timberlake,
Gunther Schlager,
Preview
|
|
摘要:
Hypertension is a complex trait of unknown cause in humans. Mice of the inbred strain BPH/2 serve as a rodent model of human hypertension and display elevated blood pressure compared with the hypotensive strain BPL/1. An F2 intercross of BPH/2 and BPL/1 and 2 backcrosses of BPL/1 withMus spretuswere used to perform interval linkage mapping for systolic blood pressure in a genome scan. Significant linkage was observed in the F2s on chromosome 10 (logarithm of the odds score [LOD]=4.9) and on chromosome 13 in theM spretusbackcross (LOD=3.3), with additional suggestive LODs on chromosomes 2, 6, 8, and 18. In addition, several suggestive linkages were observed for phenotypes associated with human hypertension. Our study is the first reported genome-wide linkage scan for blood pressure genes in the mouse.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
18. |
Genetic Variants in the Epithelial Sodium Channel in Relation to Aldosterone and Potassium Excretion and Risk for Hypertension |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 631-637
Walter Ambrosius,
Laura Bloem,
Lifen Zhou,
John Rebhun,
Peter Snyder,
Mary Wagner,
Chunlu Guo,
J. Pratt,
Preview
|
|
摘要:
Renin and aldosterone secretion is often lower in blacks than in whites, characteristics that resemble a milder form of Liddle syndrome in which a mutation in the amiloride-sensitive epithelial sodium channel (ENaC) of the kidney results in enhanced resorption of sodium. In the present study, we looked for evidence that the intrinsic level of ENaC activity is indeed higher in blacks than in whites. In overnight urine samples collected from young people (249 white and 181 black subjects, mean age 13.4 years), the urinary aldosterone/potassium ratio, which is typically very low in Liddle syndrome, was lower in blacks than in whites: 0.421±0.024 (mean±SE) versus 0.582±0.016 nmol/mmol (P<0.0001). In addition, all but 1 of 5 molecular variants in ENaC were much more common in blacks than in whites. G442V in the β-subunit, present in 16% of the blacks and in only 1 white, was associated with parameters reflective of a greater Na retention and potentially a higher ENaC activity: a lower plasma aldosterone concentration (P=0.070), a lower urinary aldosterone excretion rate (P=0.052), a higher potassium excretion rate (P=0.048), and a lower urinary aldosterone/potassium ratio (P=0.027). In a second cohort consisting of 126 black and 161 white normotensive subjects and 232 black and 188 white hypertensive subjects, βG442V did not show a significant association with hypertension (P=0.089). On the other hand, a variant that was twice as common in whites, αT663A, was associated with being normotensive both in blacks (P=0.018) and in whites (P=0.034). Expression of either βG442V or αT663A inXenopusoocytes did not result in a change in basal Na current, consistent with the variants being in linkage disequilibrium with alleles at active loci. In conclusion, several lines of evidence are presented to suggest that ENaC activity is higher in blacks than in whites, which could contribute to racial differences in Na retention and the risk for hypertension.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
19. |
Mutants of 11β-Hydroxysteroid Dehydrogenase (11-HSD2) With Partial ActivityImproved Correlations Between Genotype and Biochemical Phenotype in Apparent Mineralocorticoid Excess |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 638-642
B. Nunez,
Fraser Rogerson,
Tomoatsu Mune,
Yoshio Igarashi,
Yuichi Nakagawa,
George Phillipov,
Asha Moudgil,
Luther Travis,
Mario Palermo,
Cedric Shackleton,
Perrin White,
Preview
|
|
摘要:
Mutations in the kidney isozyme of human 11-hydroxysteroid dehydrogenase (11-HSD2) cause apparent mineralocorticoid excess, an autosomal recessive form of familial hypertension. We studied 4 patients with AME, identifying 4 novel and 3 previously reported mutations in theHSD11B2(HSD11K) gene. Point mutations causing amino acid substitutions were introduced into a pCMV5/11HSD2 expression construct and expressed in mammalian CHOP cells. Mutations L179R and R208H abolished activity in whole cells. Mutants S180F, A237V, and A328V had 19%, 72%, and 25%, respectively, of the activity of the wild-type enzyme in whole cells when cortisol was used as the substrate and 80%, 140%, and 55%, respectively, of wild-type activity when corticosterone was used as the substrate. However, these mutant proteins were only 0.6% to 5.7% as active as the wild-type enzyme in cell lysates, suggesting that these mutations alter stability of the enzyme. In regression analyses of all AME patients with published genotypes, several biochemical and clinical parameters were highly correlated with mutant enzymatic activity, demonstrated in whole cells, when cortisol was used as the substrate. These included the ratio of urinary cortisone to cortisol metabolites (R2=0.648,P<0.0001), age at presentation (R2=0.614,P<0.0001), and birth weight (R2=0.576,P=0.0004). Approximately 5% conversion of cortisol to cortisone is predicted in subjects with mutations that completely inactivate HSD11B2, suggesting that a low level of enzymatic activity is mediated by another enzyme, possibly 11-HSD1.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
20. |
Congenic Substitution Mapping ExcludesSaas a Candidate Gene Locus for a Blood Pressure Quantitative Trait Locus on Rat Chromosome 1 |
|
Hypertension,
Volume 34,
Issue 4, Part 1,
1999,
Page 643-648
Norbert Hübner,
Young-Ae Lee,
Klaus Lindpaintner,
Detlev Ganten,
Reinhold Kreutz,
Preview
|
|
摘要:
Previously, linkage analysis in several experimental crosses between hypertensive rat strains and their contrasting reference strains have identified a major quantitative trait locus (QTL) for blood pressure on rat chromosome 1 (Chr 1) spanning theSagene locus. In this study, we report the further dissection of this Chr 1 blood pressure QTL with congenic substitution mapping. To address whether theSagene represents a candidate gene for the Chr 1 blood pressure QTL, congenic strains were developed by introgressing high blood pressure QTL alleles from the stroke-prone spontaneously hypertensive rat (SHRSP) into the normotensive Wistar-Kyoto (WKY-1) reference strain. Congenic animals carrying a chromosomal segment from stroke-prone spontaneously hypertensive rats between genetic markersMt1paandD1Rat200(including theSagene locus) show a significant increase in basal systolic and diastolic blood pressure compared with their normotensive Wistar-Kyoto progenitors (P<0.001, respectively), whereas congenic animals carrying a subfragment of this Chr 1 region defined by markersMt1paandD1Rat57(also spanning theSagene) do not show elevated basal blood pressure levels (P=0.83 andP=0.9, respectively). Similar results were obtained for NaCl-induced blood pressure values. Thus, the blood pressure QTL on Chr 1 is located centromeric to theSagene locus in a region that is syntenic to human chromosome 11p15.4-p15.3. This region excludes theSaas a blood pressure-elevating candidate gene locus on the basis of congenic substitution mapping approaches.
ISSN:0194-911X
出版商:OVID
年代:1999
数据来源: OVID
|
|